Ancora Heart Inc. announced the first patient was enrolled in the CorCinch EU study, a European multi-center clinical evaluation of the AccuCinch Ventricular Repair System as a treatment for patients with reduced ejection fraction systolic heart failure (HFrEF).

A simple change in the way health professionals track their patients’ progress has brought improved healing of life-altering open sores caused by chronic venous insufficiency (CVI) , according to a new article in the Journal for Vascular Surgery – Venous and Lymphatic Disorders.

The Radiological Society of North America (RSNA) and the American College of Radiology (ACR) will launch a new medical 3-D printing clinical data registry to collect 3-D printing data at the point of clinical care. A joint ACR-RSNA committee will govern the registry, intended to pilot in the fall of 2019.

Corindus Vascular Robotics announced it has entered into a definitive merger agreement to be acquired by Siemens Healthineers AG. Under the terms of the merger agreement, Siemens Medical Solutions, a wholly-owned subsidiary of Siemens Healthineers AG, a German stock listed company, will acquire all issued and outstanding shares of common stock of Corindus for $4.28 per share in cash, representing an aggregate purchase price of approximately $1.1 billion.

Hormone replacement therapy is a common treatment for menopause-related symptoms, and new research from the University of Pittsburgh Graduate School of Public Health reinforces the importance of tailoring hormone therapy to each patient, based on her individual risk factors for cardiovascular disease.